Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug-Receptor Bonds01:25

Drug-Receptor Bonds

Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Metal-Ligand Bonds02:51

Metal-Ligand Bonds

The hemoglobin in the blood, the chlorophyll in green plants, vitamin B-12, and the catalyst used in the manufacture of polyethylene all contain coordination compounds. Ions of the metals, especially the transition metals, are likely to form complexes.
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

hexABC seeking the physical code of DNA.

Nature communications·2026
Same author

Synthesis, Incorporation, and Translation Properties of Threose Nucleic Acid Modified Trinucleotide Cap Analogs.

ACS omega·2025
Same author

Antineoplastic and antibacterial activity of new copper(II) complexes with H₂salbu and H₄salbu Schiff base-type ligands.

Journal of inorganic biochemistry·2025
Same author

Characterization of the Systemic Effects of Casiopeina III-Ia Using an In Vivo Glioma Model: Antitumoral, Pharmacokinetics, and Immune Responses.

Archiv der Pharmazie·2025
Same author

A ratiometric theranostic nanoplatform with acid-triggered drug release and glutathione-activated fluorescence turn-on.

Journal of controlled release : official journal of the Controlled Release Society·2025
Same author

Metabolomic Effects and Their Relationship with Intracellular/Extracellular Concentrations of Casiopeinas<sup>®</sup> in Triple-Negative Mesenchymal Breast Cancer.

International journal of molecular sciences·2025

Related Experiment Video

Updated: May 17, 2026

Structure and Coordination Determination of Peptide-metal Complexes Using 1D and 2D 1H NMR
14:44

Structure and Coordination Determination of Peptide-metal Complexes Using 1D and 2D 1H NMR

Published on: December 16, 2013

Molecular recognition between DNA and a copper-based anticancer complex.

Rodrigo Galindo-Murillo1, Lena Ruíz-Azuara, Rafael Moreno-Esparza

  • 1Instituto de Química, Universidad Nacional Autónoma de México, México DF 04510, México.

Physical Chemistry Chemical Physics : PCCP
|October 18, 2012
PubMed
Summary
This summary is machine-generated.

Computational methods reveal how anticancer copper complexes bind to DNA. The copper complex (Cas) forms a coordination bond with DNA

More Related Videos

Genome-wide Mapping of Drug-DNA Interactions in Cells with COSMIC (Crosslinking of Small Molecules to Isolate Chromatin)
10:05

Genome-wide Mapping of Drug-DNA Interactions in Cells with COSMIC (Crosslinking of Small Molecules to Isolate Chromatin)

Published on: January 20, 2016

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
11:14

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 10, 2013

Related Experiment Videos

Last Updated: May 17, 2026

Structure and Coordination Determination of Peptide-metal Complexes Using 1D and 2D 1H NMR
14:44

Structure and Coordination Determination of Peptide-metal Complexes Using 1D and 2D 1H NMR

Published on: December 16, 2013

Genome-wide Mapping of Drug-DNA Interactions in Cells with COSMIC (Crosslinking of Small Molecules to Isolate Chromatin)
10:05

Genome-wide Mapping of Drug-DNA Interactions in Cells with COSMIC (Crosslinking of Small Molecules to Isolate Chromatin)

Published on: January 20, 2016

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
11:14

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 10, 2013

Area of Science:

  • Computational chemistry
  • Molecular modeling
  • Drug discovery

Background:

  • Anticancer copper complexes show promise as therapeutic agents.
  • Understanding the molecular interactions between drugs and DNA is crucial for drug design.
  • Copper complexes are investigated for their apoptosis-inducing properties.

Purpose of the Study:

  • To elucidate the specific binding site and interactions between an anticancer copper complex and DNA using computational methods.
  • To provide insights into the mechanism of action of copper-based anticancer drugs.
  • To guide the rational design of novel copper-based anticancer agents.

Main Methods:

  • Molecular dynamics simulations to identify preferred binding sites.
  • Density Functional Theory (DFT) optimizations for detailed geometry analysis.
  • Topological analysis of electron density to characterize interactions.

Main Results:

  • The copper complex [Cu(2,2'-bipyridine)(acetylacetonate)(H(2)O)](+) (Cas) binds to the deoxyribose-phosphate backbone of DNA via a coordination bond with the phosphate group.
  • Non-covalent interactions, including C-H···π, O···π(C), and O···π(N), occur between the DNA sugar moiety and the aromatic ligand of Cas.
  • The formation of the Cas-deoxyribose-phosphate adduct may initiate DNA chain hydrolysis.

Conclusions:

  • This study details the specific recognition site and interactions between an anticancer copper complex and DNA.
  • The findings offer a mechanistic understanding of how copper complexes induce apoptosis.
  • The results provide a foundation for designing improved copper-based anticancer drugs.